BOM (psychedelic)
Names | |
---|---|
Preferred IUPAC name
2-Methoxy-2-(3,4,5-trimethoxyphenyl)ethan-1-amine | |
Other names
3,4,5,beta-Tetramethoxyphenethylamine 2-(3,4,5,beta-Tetramethoxyphenyl)ethanamine β-methoxymescaline | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
InChI
| |
SMILES
| |
Properties | |
Chemical formula |
C12H19NO4 |
Molar mass | 241.287 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
BOM (3,4,5,beta-tetramethoxyphenethylamine) is a lesser-known psychedelic drug. It is the beta-methoxy derivative of mescaline. BOM was first synthesized by Alexander Shulgin. In his book PiHKAL, the minimum dosage is listed as 200 mg, and the duration unknown.[1] BOM produces few to no effects.[2] Very little data exists about its pharmacological properties, metabolism, and toxicity.
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[3]
See also
References
- ↑ BOM Entry in PiHKAL
- ↑ Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
This article is issued from Offline. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.